Cônes de croissance : Questions médicales fréquentes
Nom anglais: Growth Cones
Descriptor UI:D020439
Tree Number:A11.671.501.145.375
Termes MeSH sélectionnés :
Azithromycin
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Cônes de croissance : Questions médicales les plus fréquentes",
"headline": "Cônes de croissance : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Cônes de croissance : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-08",
"dateModified": "2025-04-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Cônes de croissance"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Axones",
"url": "https://questionsmedicales.fr/mesh/D001369",
"about": {
"@type": "MedicalCondition",
"name": "Axones",
"code": {
"@type": "MedicalCode",
"code": "D001369",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.145"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Cônes de croissance",
"alternateName": "Growth Cones",
"code": {
"@type": "MedicalCode",
"code": "D020439",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Michihiro Igarashi",
"url": "https://questionsmedicales.fr/author/Michihiro%20Igarashi",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurochemistry and Molecular Cell Biology, School of Medicine and Graduate School of Medical/Dental Sciences, Niigata University, Niigata, 951-8510, Japan."
}
},
{
"@type": "Person",
"name": "Daniel M Suter",
"url": "https://questionsmedicales.fr/author/Daniel%20M%20Suter",
"affiliation": {
"@type": "Organization",
"name": "Department of Biological Sciences, Purdue University, West Lafayette, IN, USA. dsuter@purdue.edu."
}
},
{
"@type": "Person",
"name": "Yimin Zou",
"url": "https://questionsmedicales.fr/author/Yimin%20Zou",
"affiliation": {
"@type": "Organization",
"name": "Neurobiology Section, Biological Sciences Division, University of California San Diego, La Jolla, CA 92093 yzou@ucsd.edu."
}
},
{
"@type": "Person",
"name": "Jeffrey van Haren",
"url": "https://questionsmedicales.fr/author/Jeffrey%20van%20Haren",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Snehal S Mahadik",
"url": "https://questionsmedicales.fr/author/Snehal%20S%20Mahadik",
"affiliation": {
"@type": "Organization",
"name": "Program in Molecular, Cellular, and Developmental Biology, Department of Molecular Biosciences, The University of Kansas, 1200 Sunnyside Avenue, 5049 Haworth Hall, Lawrence, KS 66045."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Increase in veterinary prescriptions of azithromycin during the COVID-19 pandemic in Brazil.",
"datePublished": "2023-07-27",
"url": "https://questionsmedicales.fr/article/37515794",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3855/jidc.17597"
}
},
{
"@type": "ScholarlyArticle",
"name": "Neonatal Azithromycin Administration and Growth during Infancy: A Randomized Controlled Trial.",
"datePublished": "2023-03-27",
"url": "https://questionsmedicales.fr/article/36972694",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4269/ajtmh.22-0763"
}
},
{
"@type": "ScholarlyArticle",
"name": "Efficacy of azithromycin in treating Ureaplasma urealyticum: a systematic review and meta-analysis.",
"datePublished": "2023-03-16",
"url": "https://questionsmedicales.fr/article/36927441",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12879-023-08102-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development of a dry powder formulation for pulmonary delivery of azithromycin-loaded nanoparticles.",
"datePublished": "2024-10-14",
"url": "https://questionsmedicales.fr/article/39469425",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/jpps.2024.13635"
}
},
{
"@type": "ScholarlyArticle",
"name": "Severe papulopustular rosacea successfully treated with a combination of oral azithromycin and isotretinoin.",
"datePublished": "2022-10-05",
"url": "https://questionsmedicales.fr/article/36165496",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/09546634.2022.2129953"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Cellules",
"item": "https://questionsmedicales.fr/mesh/D002477"
},
{
"@type": "ListItem",
"position": 3,
"name": "Neurones",
"item": "https://questionsmedicales.fr/mesh/D009474"
},
{
"@type": "ListItem",
"position": 4,
"name": "Neurofibres",
"item": "https://questionsmedicales.fr/mesh/D009412"
},
{
"@type": "ListItem",
"position": 5,
"name": "Axones",
"item": "https://questionsmedicales.fr/mesh/D001369"
},
{
"@type": "ListItem",
"position": 6,
"name": "Cônes de croissance",
"item": "https://questionsmedicales.fr/mesh/D020439"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Cônes de croissance - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Cônes de croissance",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Cônes de croissance",
"description": "Comment identifier un cône de croissance ?\nQuels tests sont utilisés pour étudier les cônes de croissance ?\nLes cônes de croissance peuvent-ils être visualisés in vivo ?\nQuels marqueurs sont utilisés pour les cônes de croissance ?\nPeut-on évaluer la fonction des cônes de croissance ?",
"url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Azithromycin&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Cônes de croissance",
"description": "Quels symptômes indiquent un dysfonctionnement des cônes de croissance ?\nLes cônes de croissance affectent-ils le comportement ?\nComment les cônes de croissance sont-ils liés à la douleur ?\nLes troubles de la croissance neuronale causent-ils des symptômes physiques ?\nLes symptômes neurologiques sont-ils toujours présents avec des cônes de croissance anormaux ?",
"url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Azithromycin&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Cônes de croissance",
"description": "Peut-on prévenir les anomalies des cônes de croissance ?\nQuel rôle joue l'environnement dans le développement des cônes de croissance ?\nLes facteurs génétiques influencent-ils les cônes de croissance ?\nComment le stress maternel impacte-t-il le développement neuronal ?\nLes vaccinations influencent-elles le développement neuronal ?",
"url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Azithromycin&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Cônes de croissance",
"description": "Quels traitements existent pour les troubles liés aux cônes de croissance ?\nLa chirurgie peut-elle corriger des anomalies des cônes de croissance ?\nLes médicaments peuvent-ils aider à la régénération des cônes de croissance ?\nY a-t-il des thérapies innovantes pour les cônes de croissance ?\nComment la réhabilitation aide-t-elle les patients ?",
"url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Azithromycin&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Cônes de croissance",
"description": "Quelles complications peuvent survenir avec des cônes de croissance anormaux ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications neurologiques sont-elles fréquentes ?\nLes complications peuvent-elles être prévenues ?",
"url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Azithromycin&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Cônes de croissance",
"description": "Quels sont les facteurs de risque pour les anomalies des cônes de croissance ?\nLe tabagisme maternel est-il un facteur de risque ?\nL'exposition à des toxines affecte-t-elle les cônes de croissance ?\nLes troubles génétiques augmentent-ils le risque ?\nLe manque de soins prénatals est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D020439?mesh_terms=Azithromycin&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier un cône de croissance ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'observation microscopique des neurones en culture permet d'identifier les cônes de croissance."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour étudier les cônes de croissance ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques comme la microscopie à fluorescence et l'immunohistochimie sont couramment utilisées."
}
},
{
"@type": "Question",
"name": "Les cônes de croissance peuvent-ils être visualisés in vivo ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des techniques d'imagerie avancées permettent de visualiser les cônes de croissance in vivo."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont utilisés pour les cônes de croissance ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs comme la tubuline et la protéine GAP-43 sont souvent utilisés pour les identifier."
}
},
{
"@type": "Question",
"name": "Peut-on évaluer la fonction des cônes de croissance ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests fonctionnels mesurent la capacité des cônes à diriger la croissance axonale."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un dysfonctionnement des cônes de croissance ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies dans la croissance neuronale peuvent entraîner des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les cônes de croissance affectent-ils le comportement ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans leur développement peuvent influencer le comportement et les fonctions cognitives."
}
},
{
"@type": "Question",
"name": "Comment les cônes de croissance sont-ils liés à la douleur ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des cônes de croissance mal orientés peuvent contribuer à des douleurs neuropathiques."
}
},
{
"@type": "Question",
"name": "Les troubles de la croissance neuronale causent-ils des symptômes physiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles peuvent entraîner des déficits moteurs ou sensoriels selon la région affectée."
}
},
{
"@type": "Question",
"name": "Les symptômes neurologiques sont-ils toujours présents avec des cônes de croissance anormaux ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, mais des anomalies peuvent augmenter le risque de troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les anomalies des cônes de croissance ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines anomalies peuvent être évitées par une bonne nutrition et des soins prénatals."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'environnement dans le développement des cônes de croissance ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un environnement enrichi peut favoriser un développement neuronal sain et fonctionnel."
}
},
{
"@type": "Question",
"name": "Les facteurs génétiques influencent-ils les cônes de croissance ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des mutations génétiques peuvent affecter le développement et la fonction des cônes."
}
},
{
"@type": "Question",
"name": "Comment le stress maternel impacte-t-il le développement neuronal ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress maternel peut nuire au développement des cônes de croissance et à la santé neuronale."
}
},
{
"@type": "Question",
"name": "Les vaccinations influencent-elles le développement neuronal ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations ne nuisent pas au développement neuronal et sont essentielles pour la santé."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les troubles liés aux cônes de croissance ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie physique, la médication et la rééducation neurologique."
}
},
{
"@type": "Question",
"name": "La chirurgie peut-elle corriger des anomalies des cônes de croissance ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, la chirurgie peut être envisagée pour corriger des malformations structurelles."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider à la régénération des cônes de croissance ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments favorisent la régénération axonale et la plasticité neuronale."
}
},
{
"@type": "Question",
"name": "Y a-t-il des thérapies innovantes pour les cônes de croissance ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies géniques et cellulaires sont en cours d'étude pour améliorer la régénération neuronale."
}
},
{
"@type": "Question",
"name": "Comment la réhabilitation aide-t-elle les patients ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La réhabilitation aide à restaurer les fonctions perdues et à améliorer la qualité de vie."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des cônes de croissance anormaux ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles neurologiques, des déficits moteurs et des douleurs chroniques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être atténuées par des traitements précoces et appropriés."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent réduire la qualité de vie en limitant les activités quotidiennes."
}
},
{
"@type": "Question",
"name": "Les complications neurologiques sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications neurologiques sont courantes chez les patients avec des anomalies des cônes."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être prévenues ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être prévenues par un suivi médical régulier et des interventions précoces."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les anomalies des cônes de croissance ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des infections prénatales et des toxines environnementales."
}
},
{
"@type": "Question",
"name": "Le tabagisme maternel est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme pendant la grossesse augmente le risque d'anomalies du développement neuronal."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines affecte-t-elle les cônes de croissance ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines environnementales peut nuire au développement neuronal."
}
},
{
"@type": "Question",
"name": "Les troubles génétiques augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains troubles génétiques sont associés à des anomalies dans le développement des cônes."
}
},
{
"@type": "Question",
"name": "Le manque de soins prénatals est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un manque de soins prénatals peut augmenter le risque de complications neurologiques."
}
}
]
}
]
}
With the advent of the pandemic in 2020 and the lack of perspectives on the treatment of COVID-19, numerous therapeutic proposals have emerged, including hydroxychloroquine and azithromycin. Therefore...
Data on the purchase of antibiotics made under veterinary prescriptions in Brazilian pharmacies between 2014 and 2021 were collected. To assess the changes in monthly trends in the use of the selected...
The most prescribed antibiotic in all years was cephalexin (35%), followed by amoxicillin (24%). During the pandemic, sales of azithromycin substantially increased. Regression analysis showed that sin...
During the pandemic, there was no animal health situation in Brazil that required the use of this antibiotic. Veterinary prescriptions may have been an instrument for human access to azithromycin for ...
Observational studies have linked early-life antibiotic exposure to increased risk of obesity in children in high income settings. We evaluated whether neonatal antibiotic exposure led to changes in i...
Ureaplasma urealyticum is the most prevalent genital mycoplasma isolated from the urogenital tract of females, but there is no unified treatment plan. This study aimed to evaluate the efficacy of azit...
From the earliest to June 2022, published randomized controlled trials (RCTs) on azithromycin treatment of Ureaplasma urealyticum were retrieved by searching PubMed, Embase, Cochrane Library, and Web ...
Seven RCTs were finally included, involving 512 participants (240 in the experimental group, 272 in the control group). The experimental group was treated with azithromycin monotherapy, while the cont...
Regarding the meta-analysis that we performed based on existing clinical studies, azithromycin is quite effective in treating Ureaplasma urealyticum....
The COVID-19 pandemic has raised concern regarding respiratory system diseases and oral inhalation stands out as an attractive non-invasive route of administration for pulmonary diseases such as chron...
Papulopustular rosacea is notoriously a challenge to treat, and treatment options are scarce. Only limited data exist on the use of azithromycin in treatment of papulopustular rosacea. However, the un...
Cancer patients are prescribed antibiotics, such as macrolides and lactamides, for infection treatment. However, the effect of these antibiotics on NLRP3 activation remains largely unknown....
Lung cancer (A549) and prostate cancer (PC3) cell lines were primed with lipopolysaccharide (LPS) to activate NLRP3 transcription. Cells were then treated with azithromycin (Az) or ceftriaxone (Cf). N...
LPS-Az activated transcription of...
Our data suggest that Cf could suppress LPS induced NLRP3, which should be considered when selecting antibiotics for cancer treatment. In contrast, the effect of Az on LPS primed NLRP3 and the inflamm...
The presence of azithromycin in the human plasma of pediatric patients was determined with a UHPLC-MS/MS assay. Sample preparation was done by protein precipitation, and the separation was achieved on...
Bacterial sexually transmitted infections (STIs) pose a major public health problem. The emergence of antibiotic-resistant strains of Neisseria gonorrhoeae represents a serious threat to successful tr...
To identify molecular mechanisms implicated in azithromycin resistance in strains isolated from patients over a three-year period in a university hospital in Switzerland....
From January 2020 to December 2022, 34 isolates (one per patient) were recovered from samples analyzed at the University Hospital of Lausanne. Eight genes involved in azithromycin resistance were sequ...
With a cutoff value of 1 mg/L, 15 isolates were considered as being resistant to azithromycin, whereas the remaining 19 were susceptible. The C2597T mutation in 3 or 4 of the rrl allele confer a mediu...
Resistance to azithromycin was explained by the presence of mutations in many different copies of 23S RNA ribosomal genes and their regulatory genes. Other mutations, previously reported to be associa...
Tobramycin inhalation solution (TIS) and chronic azithromycin (AZ) have known clinical benefits for children with CF, likely due to antimicrobial and anti-inflammatory activity. The effects of chronic...
Substantial changes in bacterial communities (total bacterial load, diversity and relative abundance of specific taxa) were observed by week 3 of TIS treatment for both the AZ and placebo groups. On a...
This study provides further evidence that the mechanism for AZ's effect on clinical outcomes is not due solely to action on airway microbial composition....
The effects of azithromycin mass drug administration (MDA) on trachoma and yaws have been addressed. However, the secondary effects of azithromycin MDA remain unclear. This study aimed to explore the ...